UBS AM
NXTM

UBS AM’s NxStage Medical Inc. NXTM Stock Holding History

UBS AM’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-51,977
Closed -$1.49M – 2840
2018
Q4 		$1.49M Buy
51,977
+8,483
+20% +$241K ﹤0.01% 1559
2018
Q3 		$1.21M Buy
43,494
+445
+1% +$12.5K ﹤0.01% 1734
2018
Q2 		$1.2M Sell
43,049
-5,344
-11% -$143K ﹤0.01% 1739
2018
Q1 		$1.2M Buy
48,393
+7,690
+19% +$187K ﹤0.01% 1707
2017
Q4 		$986K Buy
40,703
+2,420
+6% +$63.8K ﹤0.01% 1758
2017
Q3 		$1.06M Buy
38,283
+4,417
+13% +$118K ﹤0.01% 1682
2017
Q2 		$849K Buy
33,866
+1,334
+4% +$33K ﹤0.01% 1724
2017
Q1 		$873K Buy
32,532
+19,434
+148% +$537K ﹤0.01% 1689
2016
Q4 		$343K Sell
13,098
-18,100
-58% -$448K ﹤0.01% 1893
2016
Q3 		$780K Hold
31,198
– – ﹤0.01% 1776
2016
Q2 		$676K Buy
31,198
+3,200
+11% +$57.1K ﹤0.01% 1816
2016
Q1 		$420K Sell
27,998
-14,700
-34% -$246K ﹤0.01% 2017
2015
Q4 		$936K Buy
42,698
+1,600
+4% +$29.8K ﹤0.01% 1773
2015
Q3 		$648K Buy
41,098
+13,900
+51% +$223K ﹤0.01% 1888
2015
Q2 		$389K Buy
27,198
+2,200
+9% +$37.3K ﹤0.01% 2201
2015
Q1 		$432K Buy
24,998
+1,200
+5% +$21.2K ﹤0.01% 2058
2014
Q4 		$427K Buy
23,798
+2,500
+12% +$40.3K ﹤0.01% 2028
2014
Q3 		$280K Hold
21,298
– – ﹤0.01% 2184
2014
Q2 		$306K Buy
21,298
+800
+4% +$10.4K ﹤0.01% 2167
2014
Q1 		$261K Hold
20,498
– – ﹤0.01% 2271
2013
Q4 		$205K Hold
20,498
– – ﹤0.01% 2362
2013
Q3 		$270K Hold
20,498
– – ﹤0.01% 2148
2013
Q2 		$293K Buy
+20,498
New +$258K ﹤0.01% 2006

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

UBS AM's NXTM Position: Q1 2019 in Review

UBS AM sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 51,977 shares — an estimated $1.49M sold.

UBS AM first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $1.49M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • UBS AM reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • UBS AM sold 51,977 NxStage Medical Inc. shares in Q1 2019, an estimated $1.49M.
  • UBS AM first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • UBS AM's NxStage Medical Inc. position peaked at $1.49M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.